116 related articles for article (PubMed ID: 35701334)
21. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.
Gerl A; Mühlbayer D; Hansmann G; Mraz W; Hiddemann W
Cancer; 2001 Apr; 91(7):1297-303. PubMed ID: 11283930
[TBL] [Abstract][Full Text] [Related]
22. Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivors.
Tarsitano MG; Bandak M; Jørgensen N; Skakkebaek NE; Juul A; Lenzi A; Daugaard G; Rajpert-De Meyts E
Andrology; 2018 Sep; 6(5):748-755. PubMed ID: 29981219
[TBL] [Abstract][Full Text] [Related]
23. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.
Kim SH; Park JJ; Kim KH; Yang HJ; Kim DS; Lee CH; Jeon YS; Shim SR; Kim JH
Int Urol Nephrol; 2021 Sep; 53(9):1733-1746. PubMed ID: 34089171
[TBL] [Abstract][Full Text] [Related]
25. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
26. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.
Howell SJ; Radford JA; Ryder WD; Shalet SM
J Clin Oncol; 1999 May; 17(5):1493-8. PubMed ID: 10334536
[TBL] [Abstract][Full Text] [Related]
27. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
28. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
29. Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants.
Curtis PJ; Berends L; van der Velpen V; Jennings A; Haag L; Chandra P; Kay CD; Rimm EB; Cassidy A
Clin Nutr; 2022 Jan; 41(1):165-176. PubMed ID: 34883305
[TBL] [Abstract][Full Text] [Related]
30. Testosterone Replacement Therapy and Components of the Metabolic Syndrome.
Anaissie J; Roberts NH; Wang P; Yafi FA
Sex Med Rev; 2017 Apr; 5(2):200-210. PubMed ID: 28202344
[TBL] [Abstract][Full Text] [Related]
31. Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial.
Huang G; Wharton W; Bhasin S; Harman SM; Pencina KM; Tsitouras P; Li Z; Hally KA; Asthana S; Storer TW; Basaria S
Lancet Diabetes Endocrinol; 2016 Aug; 4(8):657-665. PubMed ID: 27377542
[TBL] [Abstract][Full Text] [Related]
32. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency: a double-blind, randomized, placebo-controlled trial.
Olesen TB; Glintborg D; Jøhnk F; Olsen MH; Andersen MS
J Hypertens; 2024 May; 42(5):893-901. PubMed ID: 38088425
[TBL] [Abstract][Full Text] [Related]
33. Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.
Skinner JW; Otzel DM; Bowser A; Nargi D; Agarwal S; Peterson MD; Zou B; Borst SE; Yarrow JF
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):465-481. PubMed ID: 29542875
[TBL] [Abstract][Full Text] [Related]
34. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
Hart RJ; Doherty DA; Mori TA; Adams LA; Huang RC; Minaee N; Handelsman DJ; McLachlan R; Norman RJ; Dickinson JE; Olynyk JK; Beilin LJ
Hum Reprod; 2019 Mar; 34(3):389-402. PubMed ID: 30576537
[TBL] [Abstract][Full Text] [Related]
35. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis.
Mulligan T; Iranmanesh A; Kerzner R; Demers LW; Veldhuis JD
Eur J Endocrinol; 1999 Sep; 141(3):257-66. PubMed ID: 10474123
[TBL] [Abstract][Full Text] [Related]
36. Altered Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect.
Willemse PH; Sleijfer DT; Sluiter WJ; Schraffordt Koops H; Doorenbos H
Acta Endocrinol (Copenh); 1983 Apr; 102(4):616-24. PubMed ID: 6133401
[TBL] [Abstract][Full Text] [Related]
37. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
38. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.
Vartolomei MD; Kimura S; Vartolomei L; Shariat SF
Eur Urol Focus; 2020 Jan; 6(1):170-177. PubMed ID: 30017901
[TBL] [Abstract][Full Text] [Related]
39. Luteinizing hormone receptors and testosterone production in whole testes and purified Leydig cells from the mouse: differences among inbred strains.
Stalvey JR; Payne AH
Endocrinology; 1983 May; 112(5):1696-701. PubMed ID: 6299705
[TBL] [Abstract][Full Text] [Related]
40. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
